Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  349 نتائج ل ""Tofacitinib""

فلترة النتائج

Subject : protein kinase inhibitors
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and efficacy of tofacitinib in 97 alopecia areata patients.

  • Authors : Nasimi M; Dermatology, Dermatology Department, Tehran University of Medical Sciences, Tehran, Iran.; Abedini R

Subjects: Pyrimidines*/Pyrimidines*/Pyrimidines*/adverse effects ; Pyrimidines*/Pyrimidines*/Pyrimidines*/administration & dosage ; Pyrimidines*/Pyrimidines*/Pyrimidines*/therapeutic use

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Sep; Vol. 23 (9), pp. 2807-2813. Date of Electronic Publication: 2024 May 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Editorial & Opinion

Granulomatous reaction to permanent eyebrow makeup successfully treated with oral tofacitinib.

  • Authors : Sun YH; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Lao LM

Subjects: Eyebrows* ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/adverse effects; Humans

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Jul; Vol. 22 (7), pp. 2131-2132. Date of Electronic Publication: 2023 Feb 10.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.

  • Authors : Valli A; Molecular Immunology Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Kuuliala K

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2022 Dec 15; Vol. 210 (2), pp. 141-150.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.

  • Authors : Yu DA; Department of Dermatology, Seoul National University College of Medicine, Korea.; Kim YE

Subjects: Alopecia Areata/Alopecia Areata/Alopecia Areata/*drug therapy ; Nitriles/Nitriles/Nitriles/*therapeutic use ; Piperidines/Piperidines/Piperidines/*therapeutic use

  • Source: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2021 Sep-Oct; Vol. 87 (5), pp. 621-627.Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.

  • Authors : Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Su C

Subjects: Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Piperidines/Piperidines/Piperidines/*administration & dosage ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*administration & dosage

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2021 Jul 05; Vol. 15 (7), pp. 1130-1141.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Off-label studies on tofacitinib in dermatology: a review.

  • Authors : Tegtmeyer K; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Zhao J

Subjects: Piperidines/Piperidines/Piperidines/*administration & dosage ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*therapeutic use ; Pyrimidines/Pyrimidines/Pyrimidines/*administration & dosageDiffuse alopecia

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2021 Jun; Vol. 32 (4), pp. 399-409. Date of Electronic Publication: 2019 Oct 03.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.

  • Authors : Verstockt B; Imelda GI Clinical Research Center, Imelda General Hospital, Bonheiden, Belgium.; Department of Gastroenterology and Hepatology, KU Leuven, University Hospitals Leuven, Leuven, Belgium.

Subjects: Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Piperidines/Piperidines/Piperidines/*adverse effects ; Pneumonia/Pneumonia/Pneumonia/*chemically induced

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2021 Apr 06; Vol. 15 (4), pp. 692-693.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad.

  • Authors : Okita R; Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan.; Division of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan.

Subjects: Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/*drug effects ; Interferon-gamma/Interferon-gamma/Interferon-gamma/*adverse effects ; Killer Cells, Natural/Killer Cells, Natural/Killer Cells, Natural/*immunology

  • Source: Thoracic cancer [Thorac Cancer] 2021 Mar; Vol. 12 (6), pp. 775-782. Date of Electronic Publication: 2021 Jan 24.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.

  • Authors : Isailovic N; Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy.; Ceribelli A

Subjects: Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Lymphocytes/Lymphocytes/Lymphocytes/*drug effects ; Piperidines/Piperidines/Piperidines/*therapeutic use

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2021 Aug; Vol. 205 (2), pp. 142-149. Date of Electronic Publication: 2021 May 28.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tofacitinib for the treatment of refractory pyoderma gangrenosum.

  • Authors : Orfaly VE; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.; Kovalenko I

Subjects: Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*therapeutic use ; Piperidines/Piperidines/Piperidines/*therapeutic use ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*therapeutic use

  • Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1082-1085. Date of Electronic Publication: 2021 May 29.Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  349 نتائج ل ""Tofacitinib""